** Shares of diagnostics company QTNT.O surge ~21% to
$9.17 in extended trade after its COVID-19 antibody test shows
strong results
** Company says it would apply for European certification
and FDA emergency use authorization in the next few days for its
antibody test
** Says results showed test had 100% sensitivity and 99.4%
specificity urn:newsml:reuters.com:*:nGNX22C6nf
** Up to Monday's close, QTNT had fallen ~20% this year
(Reporting by Akanksha Rana in Bengaluru)
((akanksha.rana@thomsonreuters.com;))